- Home
- PKE vs DRTS Comparison
PKE vs DRTS Comparison
Compare PKE & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PKE
- DRTS
- Stock Information
- Founded
- PKE 1954
- DRTS 2015
- Country
- PKE United States
- DRTS Israel
- Employees
- PKE N/A
- DRTS N/A
- Industry
- PKE Military/Government/Technical
- DRTS Medical/Dental Instruments
- Sector
- PKE Industrials
- DRTS Health Care
- Exchange
- PKE Nasdaq
- DRTS Nasdaq
- Market Cap
- PKE 260.2M
- DRTS 262.6M
- IPO Year
- PKE N/A
- DRTS N/A
- Fundamental
- Price
- PKE $13.65
- DRTS $2.99
- Analyst Decision
- PKE
- DRTS Strong Buy
- Analyst Count
- PKE 0
- DRTS 2
- Target Price
- PKE N/A
- DRTS $8.00
- AVG Volume (30 Days)
- PKE 44.8K
- DRTS 51.5K
- Earning Date
- PKE 05-15-2025
- DRTS 05-19-2025
- Dividend Yield
- PKE 3.66%
- DRTS N/A
- EPS Growth
- PKE N/A
- DRTS N/A
- EPS
- PKE 0.29
- DRTS N/A
- Revenue
- PKE $62,026,000.00
- DRTS N/A
- Revenue This Year
- PKE N/A
- DRTS N/A
- Revenue Next Year
- PKE N/A
- DRTS N/A
- P/E Ratio
- PKE $47.07
- DRTS N/A
- Revenue Growth
- PKE 10.75
- DRTS N/A
- 52 Week Low
- PKE $11.96
- DRTS $1.75
- 52 Week High
- PKE $15.57
- DRTS $4.39
- Technical
- Relative Strength Index (RSI)
- PKE 51.88
- DRTS 55.04
- Support Level
- PKE $13.51
- DRTS $2.95
- Resistance Level
- PKE $14.09
- DRTS $3.12
- Average True Range (ATR)
- PKE 0.54
- DRTS 0.21
- MACD
- PKE -0.00
- DRTS -0.00
- Stochastic Oscillator
- PKE 62.45
- DRTS 31.33
About PKE Park Aerospace Corp.
Park Aerospace Corp designs develop and manufactures engineered, advanced composite materials and composite structures and assemblies and low-volume tooling for the aerospace markets and prototype tooling for such structures and assemblies. Geographically, the company derives a majority of revenue from North America and also has a presence in a company operates its business in Asia and Europe. It offers advanced composite Prepregs for Aircraft Structures and Interiors, Sigma Strut and Alpha Strut.
About DRTS Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company derives maximum revenue from Israel.